Robert L. Capizzi

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

Seth A. Rudnick, E Cadman, Robert L. Capizzi et al. · Cancer · 1979 · 287 citations · Full text

Hematological Malignancy, Neuro-oncology, Disease Refractory +15

Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast Cancer

Hyman B. Muss, L. Douglas Case, Frederick Richards et al. · New England Journal of Medicine · 1991 · 192 citations

<scp>L</scp>-Asparaginase: Clinical, Biochemical, Pharmacological, and Immunological Studies

Robert L. Capizzi · Annals of Internal Medicine · 1971 · 181 citations

A table for the estimation of the spontaneous mutations rate of cells in culture

Robert L. Capizzi, Johnson W. Jameson · Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis · 1973 · 148 citations

Human Cell, Somatic Variant, Medicine +8

Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U in patients with acute leukemia.

Robert L. Capizzi, Jin‐Long Yang, Emily Cheng et al. · Journal of Clinical Oncology · 1983 · 125 citations

Hematological Malignancy, Apparent Postinfusion Kinetics, Pharmacological Study +12